Clinical trial
KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer
NCT06145139 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer
- Lead sponsor
- University of Aarhus
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 1, 2023
- Completion date
- June 1, 2033
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cancer